Skin Substitutes Market - 2021-2031
The Skin Substitutes Market was valued at US$ 946.4 million in 2021 and is anticipated to reach US$ 2,078.3 million by 2031, at a CAGR of 0.155 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Skin Substitutes Market.
This report delivers a comprehensive overview of the Skin Substitutes Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Skin Substitutes Market. The Skin Substitutes Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2031.
Skin Substitutes Market Scope:
By Type
This report delivers a comprehensive overview of the Skin Substitutes Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Skin Substitutes Market. The Skin Substitutes Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2031.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Skin Substitutes Market.
This report delivers a comprehensive overview of the Skin Substitutes Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Skin Substitutes Market. The Skin Substitutes Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2031.
Skin Substitutes Market Scope:
By Type
- Synthetic skin substitute
- Biosynthetic skin substitute
- Biological skin substitute
- Burn injuries
- Diabetic foot ulcers
- Chronic wounds
- Others
- Hospitals
- Other healthcare facilities
- Amarantus BioScience Holdings
- Organogenesis, Inc.
- Acelity L.P., Inc.
- Smith & Nephew plc
- BSN Medical
- Molnlycke Health Care
- Integra LifeSciences Corporation
- Medtronic
- Tissue Regenix Ltd.
- Stratatech Corporation
- ConVatec(LIST NOT EXHAUSTIVE)
This report delivers a comprehensive overview of the Skin Substitutes Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Skin Substitutes Market. The Skin Substitutes Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2031.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
- Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
- South America (Colombia, Brazil, Argentina, Rest of South America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
- Increase Your Customer Base by 3X using our Partner Identification tool
- Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
- Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
- Prioritize partners by strategic fit rather than general capability.
- Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
- Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
- White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
- Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
- Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
- Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
1. METHODOLOGY AND SCOPE
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. MARKET DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Number of Chronic Skin diseases
4.1.1.2. A rise in the incidence of burn injuries
4.1.1.3. Rising incidence of diabetes and the growing geriatric population
4.1.1.4. Newer approaches in tissue-engineered skin substitutes
4.1.2. Restraints
4.1.2.1. Lack of inability of reproducing skin appendages and capability of replacing lost dermis
4.1.2.2. Stringent regulations and limitations of skin substitutes
4.1.2.3. High cost and lack of availability of the skilled plastic surgeons
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY FORCES
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. Product Innovation, if any
6. BY TYPE
6.1. Introduction
6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
6.1.2. Market Attractiveness Index, By Type
6.2. Synthetic skin substitute
6.2.1. Introduction
6.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
6.3. Biosynthetic skin substitute
6.4. Biological skin substitute
6.4.1. Allograft
6.4.1.1. Cellular
6.4.1.2. Acellular
6.4.2. Xenograft
6.4.3. Amnion
7. BY APPLICATION
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application
7.2. Burn injuries
7.2.1. Introduction
7.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
7.3. Diabetic foot ulcers
7.4. Chronic wounds
7.5. Others
8. BY END USER
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals
8.2.1. Introduction
8.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
8.3. Other healthcare facilities
9. BY REGION
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
9.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.2.6.1. The U.S.
9.2.6.2. Canada
9.2.6.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
9.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.3.6.1. Germany
9.3.6.2. The U.K.
9.3.6.3. France
9.3.6.4. Italy
9.3.6.5. Spain
9.3.6.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
9.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.4.6.1. Brazil
9.4.6.2. Argentina
9.4.6.3. Rest of South America
9.5. Asia Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
9.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.5.6.1. China
9.5.6.2. India
9.5.6.3. Japan
9.5.6.4. Australia
9.5.6.5. Rest of Asia Pacific
9.6. The Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
10. COMPETITIVE LANDSCAPE
10.1. Competitive Scenario
10.2. Competitor Strategy Analysis
10.3. Comparative Product Portfolio Analysis
10.4. Market Positioning/Share Analysis
10.5. Mergers and Acquisitions Analysis
11. COMPANY PROFILES
11.1. Amarantus BioScience Holdings
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Key Highlights
11.1.4. Financials Overview
11.2. Organogenesis, Inc.
11.3. Acelity L.P., Inc.
11.4. Smith & Nephew plc
11.5. BSN Medical
11.6. Molnlycke Health Care
11.7. Integra LifeSciences Corporation
11.8. Medtronic
11.9. Tissue Regenix Ltd.
11.10. Stratatech Corporation
11.11. ConVatec(*LIST NOT EXHAUSTIVE)
12. DATAM INTELLIGENCE
12.1. Appendix
12.2. About Us and Method of Fixation
12.3. Contact Us
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. MARKET DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Number of Chronic Skin diseases
4.1.1.2. A rise in the incidence of burn injuries
4.1.1.3. Rising incidence of diabetes and the growing geriatric population
4.1.1.4. Newer approaches in tissue-engineered skin substitutes
4.1.2. Restraints
4.1.2.1. Lack of inability of reproducing skin appendages and capability of replacing lost dermis
4.1.2.2. Stringent regulations and limitations of skin substitutes
4.1.2.3. High cost and lack of availability of the skilled plastic surgeons
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY FORCES
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. Product Innovation, if any
6. BY TYPE
6.1. Introduction
6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
6.1.2. Market Attractiveness Index, By Type
6.2. Synthetic skin substitute
6.2.1. Introduction
6.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
6.3. Biosynthetic skin substitute
6.4. Biological skin substitute
6.4.1. Allograft
6.4.1.1. Cellular
6.4.1.2. Acellular
6.4.2. Xenograft
6.4.3. Amnion
7. BY APPLICATION
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application
7.2. Burn injuries
7.2.1. Introduction
7.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
7.3. Diabetic foot ulcers
7.4. Chronic wounds
7.5. Others
8. BY END USER
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals
8.2.1. Introduction
8.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
8.3. Other healthcare facilities
9. BY REGION
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
9.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.2.6.1. The U.S.
9.2.6.2. Canada
9.2.6.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
9.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.3.6.1. Germany
9.3.6.2. The U.K.
9.3.6.3. France
9.3.6.4. Italy
9.3.6.5. Spain
9.3.6.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
9.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.4.6.1. Brazil
9.4.6.2. Argentina
9.4.6.3. Rest of South America
9.5. Asia Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
9.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.5.6.1. China
9.5.6.2. India
9.5.6.3. Japan
9.5.6.4. Australia
9.5.6.5. Rest of Asia Pacific
9.6. The Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
10. COMPETITIVE LANDSCAPE
10.1. Competitive Scenario
10.2. Competitor Strategy Analysis
10.3. Comparative Product Portfolio Analysis
10.4. Market Positioning/Share Analysis
10.5. Mergers and Acquisitions Analysis
11. COMPANY PROFILES
11.1. Amarantus BioScience Holdings
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Key Highlights
11.1.4. Financials Overview
11.2. Organogenesis, Inc.
11.3. Acelity L.P., Inc.
11.4. Smith & Nephew plc
11.5. BSN Medical
11.6. Molnlycke Health Care
11.7. Integra LifeSciences Corporation
11.8. Medtronic
11.9. Tissue Regenix Ltd.
11.10. Stratatech Corporation
11.11. ConVatec(*LIST NOT EXHAUSTIVE)
12. DATAM INTELLIGENCE
12.1. Appendix
12.2. About Us and Method of Fixation
12.3. Contact Us
